NCT04245306

Brief Summary

This study aims to evaluate the relevance of a new computerized test for pragmatic inferences (TIPi) in children aged 8 to 12 YO, presenting a typical development, autism spectrum disorders, another neurodevelopmental condition and attention-deficit/hyperactivity disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 28, 2020

Completed
10 days until next milestone

Study Start

First participant enrolled

February 7, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2020

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2023

Completed
Last Updated

October 28, 2024

Status Verified

November 1, 2023

Enrollment Period

Same day

First QC Date

January 17, 2020

Last Update Submit

October 24, 2024

Conditions

Keywords

pragmatic inferencesnon-literal languageautismattention-deficithyperactivity disorderADHD

Outcome Measures

Primary Outcomes (1)

  • Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to TD children in the composite score of the TIPi.

    The dissociation between the developmental trajectories of these two groups will be assessed by comparing the coefficients of the linear regressions linking performance in the TIPi (composite score) and chronological age in these two groups.

    One day

Secondary Outcomes (3)

  • Sensitivity of the TIPi composite score (measuring pragmatic inferencing) to typical development in the targeted age range: 8 to 12 years oldin the targeted age range: 8 to 12 years old

    One day

  • The TIPi composite score provides additional information compared to other cognitive assessments typically provided in the global assessment of children with ASD

    One day

  • Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to children with DLD in the composite score of the TIPi.

    One day

Study Arms (4)

Children with Autism Spectrum Disorders

EXPERIMENTAL

A group of 25 children with autism spectrum disorders (ASD)

Other: computerized test for pragmatic inferences

Typically Developing children

ACTIVE COMPARATOR

A larger group of 150 typically developing children (TD)

Other: computerized test for pragmatic inferences

Children with Developmental Language Disorders

EXPERIMENTAL

A group of 25 children with developmental language disorders (DLD)

Other: computerized test for pragmatic inferences

children with attention-deficit/hyperactivity disorder (ADHD group)

EXPERIMENTAL

25 children with attention-deficit/hyperactivity disorder (ADHD group)

Other: computerized test for pragmatic inferences

Interventions

Computerized tests

Children with Autism Spectrum DisordersChildren with Developmental Language DisordersTypically Developing childrenchildren with attention-deficit/hyperactivity disorder (ADHD group)

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age between 8 and 12 years old
  • Native French speaker
  • Informed consent of the parents and children
  • \[For ASD group\] Diagnosis of ASD provided by a trained and entitled clinician
  • \[For DLD group\] Diagnosis of DLD provided by a trained and entitled clinician
  • \[For ASD and DLD groups\] IQ above 70
  • Intellectual efficiency within the norm (ITQ \> 70), confirmed by objective results (psychometrics) in the participant's file, or collected if necessary within the framework of this study (using the WISC V);
  • Medical diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) by a competent professional, confirmed by a parental assessment (ADHD-RS-IV)

You may not qualify if:

  • Uncorrected visual impairment
  • Uncorrected auditory impairment
  • Motor disability preventing the use of a touch pad
  • \[For the TD group\] Diagnosis of any neurodevelopmental or psychiatric condition
  • \[For ASD group\] Diagnosis of language disorder of attention disorder (ADHD)
  • \[For DLD group\] Diagnosis of ASD or ADHD
  • \[For ADHD group\] Diagnosis of ASD or DLD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ch Le Vinatier

Bron, 69678, France

Location

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic DisorderAttention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersAttention Deficit and Disruptive Behavior Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Three groups of children are included to be compared, in order to test the primary and secondary hypothesis of this study : * A group of 25 children with autism spectrum disorders (ASD) * A larger group of 190 typically developing children (TD) * A group of 25 children with developmental language disorders (DLD) * A group of 25 children with attention-deficit/hyperactivity disorder (ADHD group)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2020

First Posted

January 28, 2020

Study Start

February 7, 2020

Primary Completion

February 7, 2020

Study Completion

May 4, 2023

Last Updated

October 28, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations